182 related articles for article (PubMed ID: 23211022)
21. Complete remission of aggressive T-cell LGL leukemia with pentostatin therapy: first case report.
Krackeler ML; Broome C; Lai C
Stem Cell Investig; 2020; 7():24. PubMed ID: 33437844
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous involvement by T-cell prolymphocytic leukemia presenting as livedoid vasculopathy.
Leckey BD; Kheterpal MK; Selim MA; Al-Rohil RN
J Cutan Pathol; 2021 Jul; 48(7):975-979. PubMed ID: 33837964
[TBL] [Abstract][Full Text] [Related]
23. T cell-prolymphocytic leukemia detected in a patient of breast cancer at the time of recurrence: a case report.
Singhal M; Raina V; Gupta R; Das P
Cases J; 2010 Jan; 3():4. PubMed ID: 20076807
[TBL] [Abstract][Full Text] [Related]
24. T-cell prolymphocytic leukemia: a report of two cases with review of literature.
Naseem S; Gupta R; Kashyap R; Nityanand S
Indian J Hematol Blood Transfus; 2008 Dec; 24(4):178-81. PubMed ID: 23100959
[TBL] [Abstract][Full Text] [Related]
25. A case report of T cell prolymphocytic leukemia and Kaposi sarcoma and a review of T cell prolymphocytic leukemia.
Paul RN; Alizadeh L; Ajayi OI; Karpurapu H; Ganesan C; Taddesse-Heath L; Aggarwal A
Acta Haematol; 2012; 127(4):235-43. PubMed ID: 22517037
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: A single-center experience.
Dholaria BR; Ayala E; Sokol L; Nishihori T; Chavez JC; Hussaini M; Kumar A; Kharfan-Dabaja MA
Leuk Res; 2018 Apr; 67():1-5. PubMed ID: 29407180
[TBL] [Abstract][Full Text] [Related]
27. [Successful treatment of T-cell prolymphocytic leukemia (T-PLL) with fludarabine monophosphate].
Maeda A; Iwai K; Ishibashi T
Rinsho Ketsueki; 2009 Aug; 50(8):658-62. PubMed ID: 19915381
[TBL] [Abstract][Full Text] [Related]
28. [Cerebriform variant type of T cell prolymphocytic leukemia: Report of one case].
Peña C; Valladares X; Soto C; Encina A; Marinov N; Undurraga MS; Cabrera ME
Rev Med Chil; 2016 Jan; 144(1):124-8. PubMed ID: 26998991
[TBL] [Abstract][Full Text] [Related]
29. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
[TBL] [Abstract][Full Text] [Related]
30. An unusual case of T-cell prolymphocytic leukemia mimicking a cutaneous vasculitis.
Edmonds N; Guerra R; Noland MB; Schenck O; Krasner B; Gru AA
J Cutan Pathol; 2021 Oct; 48(10):1311-1316. PubMed ID: 34089197
[TBL] [Abstract][Full Text] [Related]
31. Small Cell Variant of T-Cell Prolymphocytic Leukemia with Acquired Palmoplantar Keratoderma and Cutaneous Infiltration.
Al-Musalhi B; Shehata N; Billick R
Oman Med J; 2016 Jan; 31(1):73-6. PubMed ID: 26813734
[TBL] [Abstract][Full Text] [Related]
32. Treatment of T prolymphocytic leukemia with allogeneic bone marrow transplantation.
Collins RH; Piñeiro LA; Agura ED; Fay JW
Bone Marrow Transplant; 1998 Mar; 21(6):627-8. PubMed ID: 9580345
[TBL] [Abstract][Full Text] [Related]
33. TCL-1-positive hematogones in a patient with T-cell prolymphocytic leukemia after therapy.
Hu Z; Li S; Medeiros LJ; Sun T
Hum Pathol; 2017 Jul; 65():175-179. PubMed ID: 28232160
[TBL] [Abstract][Full Text] [Related]
34. T-Cell Prolymphocytic Leukemia: An Experience from a Tertiary Cancer Centre in South India.
Babu Mc S; Anand A; Lakshmaiah KC; Babu K G; Lokanatha D; Jacob LA; Madhumathi DS; Lokesh KN; Rudresha AH; Rajeev LK; Patidar R
Int J Hematol Oncol Stem Cell Res; 2018 Apr; 12(2):132-135. PubMed ID: 30233775
[No Abstract] [Full Text] [Related]
35. Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia.
Hopfinger G; Busch R; Pflug N; Weit N; Westermann A; Fink AM; Cramer P; Reinart N; Winkler D; Fingerle-Rowson G; Stilgenbauer S; Döhner H; Kandler G; Eichhorst B; Hallek M; Herling M
Cancer; 2013 Jun; 119(12):2258-67. PubMed ID: 23512246
[TBL] [Abstract][Full Text] [Related]
36. Advances and Perspectives in the Treatment of T-PLL.
Braun T; von Jan J; Wahnschaffe L; Herling M
Curr Hematol Malig Rep; 2020 Apr; 15(2):113-124. PubMed ID: 32034661
[TBL] [Abstract][Full Text] [Related]
37. Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified.
Kawamoto K; Miyoshi H; Yanagida E; Yoshida N; Kiyasu J; Kozai Y; Morikita T; Kato T; Suzushima H; Tamura S; Muta T; Kato K; Eto T; Seki R; Nagafuji K; Sone H; Takizawa J; Seto M; Ohshima K
Eur J Haematol; 2017 May; 98(5):459-466. PubMed ID: 28129454
[TBL] [Abstract][Full Text] [Related]
38. A Rare Association: Autoimmune Hemolytic Anemia With Indolent T-Cell Prolymphocytic Leukemia.
Yahya HA; Khan N; Barta S; Nejati R
Cureus; 2020 May; 12(5):e7994. PubMed ID: 32523849
[TBL] [Abstract][Full Text] [Related]
39. T-cell prolymphocytic leukemia.
Dearden CE
Med Oncol; 2006; 23(1):17-22. PubMed ID: 16645226
[TBL] [Abstract][Full Text] [Related]
40. Infiltration of the thyroid gland by T-cell prolymphocytic leukemia.
Fujiwara K; Fukuhara T; Kitano H; Okazaki T
Thyroid; 2014 Aug; 24(8):1314-8. PubMed ID: 24762052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
